Europe Diabetes Care Devices Market Size
| Study Period | 2018 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 8.03 Billion |
| Market Size (2029) | USD 10.84 Billion |
| CAGR (2024 - 2029) | 6.18 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Europe Diabetes Care Devices Market Analysis
The Europe Diabetes Care Devices Market size is estimated at USD 8.03 billion in 2024, and is expected to reach USD 10.84 billion by 2029, growing at a CAGR of 6.18% during the forecast period (2024-2029).
The European countries are suffering from the burden of high diabetes expenditure due to its rising prevalence. Technological advancements have increased over the period in Diabetes care devices for safer and more accurate administration of insulin. Medtronic launched its first integrated smart insulin pen. The Medtronic Integrated Insulin Pen provides real-time glucose readings of patients along with insulin dose information to manage their glucose levels.
According to IDF, every year, 21,600 children are added to the type-1 diabetic population pool. These figures indicate that approximately 9% of the total healthcare expenditure is spent on diabetes in Europe. Various initiatives by the Government, such as the National Service Framework (NSF) program in the United Kingdom, are improving services by setting national standards to drive up service quality and tackle variations in care.
The Association of British HealthTech Industries (ABHI) launched a diabetes section, enabling diabetes technology companies to work together in the first forum of its kind. The ABHI group is for any health technology company interested in diabetes care, from CGM and insulin pumps to apps.
Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.
Europe Diabetes Care Devices Market Trends
The continuous glucose monitoring segment is expected to witness the highest growth rate over the forecast period
A CGM is used by inserting a small sensor into the abdomen or arm with a tiny plastic tube known as a cannula penetrating the top layer of skin. An adhesive patch holds the sensor in place, allowing it to take glucose readings in interstitial fluid throughout the day and night. Generally, the sensors must be replaced every 7 to 14 days. A small, reusable transmitter connected to the sensor allows the system to send real-time readings wirelessly to a monitor device that displays blood glucose data. Some systems come with a dedicated monitor, and some now display the information via a smartphone app.
Continuous glucose monitoring sensors use glucose oxidase to detect blood sugar levels. Glucose oxidase converts glucose to hydrogen peroxidase, which reacts with the platinum inside the sensor, producing an electrical signal to be communicated to the transmitter. Sensors are the most important part of continuous glucose monitoring devices. Technological advancements to improve the accuracy of the sensors are expected to drive segment growth during the forecast period.
The frequency of monitoring glucose levels depends on the type of diabetes, which varies from patient to patient. Type-1 diabetic patients must check their blood glucose levels regularly, monitor their blood glucose levels, and adjust the insulin dosing accordingly. The current CGM devices show a detailed representation of blood glucose patterns and tendencies compared to a routine check of glucose levels at set intervals. \
Furthermore, the current continuous glucose monitoring devices can either retrospectively display the trends in blood glucose levels by downloading the data or give a real-time picture of glucose levels through receiver displays. Such advantages helped the rise in the adoption of these products in the market.
Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.
Germany held the highest market share in the European Diabetes Care Devices Market in the current year
Diabetes is a significant health problem and one of the tremendous challenges for healthcare systems all over Germany. The prevalence of known type 1 & 2 diabetes in the German adult population is very high, along with many patients not yet diagnosed with the disease. Due to an aging population and unhealthy lifestyle, the prevalence of type 2 diabetes is expected to increase steadily over the next few years.
High-quality care, including adequate monitoring, control of risk factors, and active self-management, are the key factors for preventing complications in German patients with type 2 diabetes. The disease's growing incidence, prevalence, and progressive nature encouraged the development of new drugs to provide additional treatment options for diabetic patients.
According to the German Diabetes Centre (DDZ), about 8.5 million people in Germany are affected by diabetes. The number of people with type 2 diabetes in Germany will continue to increase over the next twenty years. German law requires public plans to cap out-of-pocket health care costs and to cover all medically necessary treatment, including insulin. Germany is one of the developed countries with advanced healthcare facilities.
Moreover, reimbursement and pricing policies are highly regulated, which drives the market. The roll-out of many new products, increasing international research collaborations in technology advancement, and increasing awareness about diabetes among people are some market opportunities for the players.
Europe Diabetes Care Devices Industry Overview
The Europe Diabetes Care Devices Market is moderately fragmented, with few significant and generic players. Manufacturers drove constant innovations to compete in the market. The major players, such as Abbott and Medtronic, underwent many mergers, acquisitions, and partnerships to establish market dominance while adhering to organic growth strategies. It is evident from the R&D spending of these companies.
Europe Diabetes Care Devices Market Leaders
-
Roche Diabetes Care
-
Medtronic PLC
-
Novo Nordisk A/S
-
Dexcom Inc.
-
Abbott
*Disclaimer: Major Players sorted in no particular order
Europe Diabetes Care Devices Market News
- Feburary 2024: Dexcom launched real-time CGM solution Dexcom ONE+ in Europe. Dexcom ONE+ is a customisable continuous glucose monitoring solution that can be worn at three different location on the body.
- June 2022: Cequr, the leader in wearable diabetes technology, released its newest and most innovative insulin delivery device, the Insulin Pen 2.0TM. The pen is small enough to be always worn on the user's body, and it also features a built-in blood glucose meter so that users can track their blood sugar throughout the day.
Europe Diabetes Care Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.3 Market Restraints
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Suppliers
- 4.4.2 Bargaining Power of Consumers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products and Services
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 Monitoring Devices
- 5.1.1 Self-monitoring Blood Glucose Devices
- 5.1.1.1 Glucometer Devices
- 5.1.1.2 Blood Glucose Test Strips
- 5.1.1.3 Lancets
- 5.1.2 Continuous Glucose Monitoring Devices
- 5.1.2.1 Sensors
- 5.1.2.2 Durables (Receivers and Transmitters)
-
5.2 Management Devices
- 5.2.1 Insulin Pump
- 5.2.1.1 Insulin Pump Device
- 5.2.1.2 Insulin Pump Reservoir
- 5.2.1.3 Infusion Set
- 5.2.2 Insulin Syringes
- 5.2.3 Cartridges in Reusable Pens
- 5.2.4 Insulin Disposable Pens
- 5.2.5 Jet Injectors
-
5.3 Geography
- 5.3.1 France
- 5.3.2 Germany
- 5.3.3 Italy
- 5.3.4 Spain
- 5.3.5 United Kingdom
- 5.3.6 Russia
- 5.3.7 Rest of Europe
6. MARKET INDICATORS
- 6.1 Type-1 Diabetes Population
- 6.2 Type-2 Diabetes Population
7. COMPETITIVE LANDSCAPE
-
7.1 COMPANY PROFILES
- 7.1.1 Dexcom Inc.
- 7.1.2 Insulet Corporation
- 7.1.3 Medtronic
- 7.1.4 Roche Diabetes Care
- 7.1.5 Novo Nordisk A/S
- 7.1.6 Ascensia Diabetes Care
- 7.1.7 Agamatrix Inc.
- 7.1.8 Bionime Corporation
- 7.1.9 LifeScan
- 7.1.10 Abbott Diabetes Care
- 7.1.11 Eli Lilly
- 7.1.12 Sanofi
- 7.1.13 Rossmax
- *List Not Exhaustive
-
7.2 COMPANY SHARE ANALYSIS
- 7.2.1 Self-monitoring Blood Glucose Devices
- 7.2.2 Continuous Glucose Monitoring Devices
- 7.2.3 Insulin Devices
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityEurope Diabetes Care Devices Industry Segmentation
Diabetes care devices are the hardware, equipment, and software used by diabetes patients to regulate blood glucose levels, prevent diabetes complications, lessen the burden of diabetes, and enhance the quality of life. The europe diabetes care devices market is segmented into monitoring devices, management devices and geography. The report offers the value (in usd) and volume (in units) for the above segments.
| Monitoring Devices | Self-monitoring Blood Glucose Devices | Glucometer Devices |
| Blood Glucose Test Strips | ||
| Lancets | ||
| Monitoring Devices | Continuous Glucose Monitoring Devices | Sensors |
| Durables (Receivers and Transmitters) | ||
| Management Devices | Insulin Pump | Insulin Pump Device |
| Insulin Pump Reservoir | ||
| Infusion Set | ||
| Management Devices | Insulin Syringes | |
| Cartridges in Reusable Pens | ||
| Insulin Disposable Pens | ||
| Jet Injectors | ||
| Geography | France | |
| Germany | ||
| Italy | ||
| Spain | ||
| United Kingdom | ||
| Russia | ||
| Rest of Europe |
Europe Diabetes Care Devices Market Research FAQs
How big is the Europe Diabetes Care Devices Market?
The Europe Diabetes Care Devices Market size is expected to reach USD 8.03 billion in 2024 and grow at a CAGR of 6.18% to reach USD 10.84 billion by 2029.
What is the current Europe Diabetes Care Devices Market size?
In 2024, the Europe Diabetes Care Devices Market size is expected to reach USD 8.03 billion.
Who are the key players in Europe Diabetes Care Devices Market?
Roche Diabetes Care, Medtronic PLC, Novo Nordisk A/S, Dexcom Inc. and Abbott are the major companies operating in the Europe Diabetes Care Devices Market.
What years does this Europe Diabetes Care Devices Market cover, and what was the market size in 2023?
In 2023, the Europe Diabetes Care Devices Market size was estimated at USD 7.53 billion. The report covers the Europe Diabetes Care Devices Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Europe Diabetes Care Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Europe Diabetes Care Devices Industry Report
Statistics for the 2024 Europe Diabetes Care Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Diabetes Care Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
